Formula Growth’s Acadia Healthcare ACHC Stock Holding History

Formula Growth’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-33,600	Closed	-$1.18M	–	140
2018 Q3	$1.18M	Sell	33,600 -5,000	-13%	-$199K	0.14%	122
2018 Q2	$1.58M	Sell	38,600 -10,000	-21%	-$403K	0.17%	106
2018 Q1	$1.9M	Sell	48,600 -170,200	-78%	-$6.24M	0.23%	92
2017 Q4	$7.14M	Buy	218,800 +175,200	+402%	+$6.07M	0.94%	34
2017 Q3	$2.08M	Hold	43,600	–	–	0.33%	71
2017 Q2	$2.15M	Hold	43,600	–	–	0.37%	68
2017 Q1	$1.9M	Sell	43,600 -65,500	-60%	-$2.66M	0.4%	75
2016 Q4	$3.61M	Buy	109,100 +81,700	+298%	+$3.17M	0.84%	37
2016 Q3	$1.36M	Hold	27,400	–	–	0.31%	96
2016 Q2	$1.52M	Hold	27,400	–	–	0.37%	88
2016 Q1	$1.51M	Sell	27,400 -1,000	-4%	-$57.1K	0.36%	95
2015 Q4	$1.77M	Buy	+28,400	New	+$1.85M	0.41%	80

Other funds holding ACHC

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Formula Growth's ACHC Position: Q4 2018 in Review

Formula Growth sold out of Acadia Healthcare (ACHC) in Q4 2018, closing a stake of 33,600 shares — an estimated $1.18M sold.

Formula Growth first reported a position in ACHC in Q4 2015 and held it in 12 quarters. The position peaked at $7.14M in Q4 2017. 254 funds tracked by Wall St. Rank hold ACHC as of Q4 2018.

Formula Growth reported no remaining Acadia Healthcare position as of Q4 2018 after selling out during the quarter.
Formula Growth sold 33,600 Acadia Healthcare shares in Q4 2018, an estimated $1.18M.
Formula Growth first reported a position in Acadia Healthcare in Q4 2015 and held it in 12 quarters.
Formula Growth's Acadia Healthcare position peaked at $7.14M in Q4 2017.
254 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2018.

Based on Formula Growth's 13F filing for Q4 2018, filed 14 Feb 2019.